| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 4025881 | Ophthalmology | 2015 | 8 Pages |
Abstract
The benefit of the AREDS formulation seems the result of a favorable response by patients in only 1 genotype group, balanced by neutral or unfavorable responses in 3 genotype groups.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Ophthalmology
Authors
Carl C. MD, Steven MSc, Brent W. MD, PhD,